BIOTALYS NV (BTLS.BR) Stock Overview
EBR:BTLS - BE0974386188 - Common Stock
BTLS.BR Key Statistics, Chart & Performance
The current stock price of BTLS.BR is 4.15 EUR. In the past month the price decreased by -9.79%. In the past year, price increased by 40.13%.
BTLS.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| YAR.OL | YARA INTERNATIONAL ASA | 11.79 | 90.76B | ||
| SDF.DE | K+S AG-REG | N/A | 2.00B | ||
| OCI.AS | OCI NV | N/A | 1.01B | ||
| ALFLO.PA | FLORENTAISE SA | N/A | 4.02M |
Related stock screener links
About BTLS.BR
Company Profile
Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.
Company Info
BIOTALYS NV
Buchtenstraat 11
Ghent OOST-VLAANDEREN BE
Employees: 63
Phone: 3292745400
BIOTALYS NV / BTLS.BR FAQ
What is the stock price of BIOTALYS NV today?
The current stock price of BTLS.BR is 4.15 EUR. The price decreased by -4.16% in the last trading session.
What is the ticker symbol for BIOTALYS NV stock?
The exchange symbol of BIOTALYS NV is BTLS and it is listed on the Euronext Brussels exchange.
On which exchange is BTLS.BR stock listed?
BTLS.BR stock is listed on the Euronext Brussels exchange.
What is the price forecast or stock price prediction for BIOTALYS NV stock?
9 analysts have analysed BTLS.BR and the average price target is 7.58 EUR. This implies a price increase of 82.7% is expected in the next year compared to the current price of 4.15. Check the BIOTALYS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOTALYS NV worth?
BIOTALYS NV (BTLS.BR) has a market capitalization of 155.71M EUR. This makes BTLS.BR a Micro Cap stock.
How many employees does BIOTALYS NV have?
BIOTALYS NV (BTLS.BR) currently has 63 employees.
What are the support and resistance levels for BIOTALYS NV (BTLS.BR) stock?
BIOTALYS NV (BTLS.BR) has a support level at 3.07 and a resistance level at 4.89. Check the full technical report for a detailed analysis of BTLS.BR support and resistance levels.
Is BIOTALYS NV (BTLS.BR) expected to grow?
The Revenue of BIOTALYS NV (BTLS.BR) is expected to decline by -52% in the next year. Check the estimates tab for more information on the BTLS.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOTALYS NV (BTLS.BR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BTLS.BR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BTLS.BR, evaluating the profitability, health, valuation and growth aspects
- BIOTALYS NV (BTLS.BR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOTALYS NV (BTLS.BR) Sales and EPS estimates to see what analysts future expectations are.
- BIOTALYS NV (BTLS.BR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOTALYS NV (BTLS.BR) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOTALYS NV (BTLS.BR) Stock Chart to make your own analysis
- BIOTALYS NV (BTLS.BR) Latest news and press-releases to stay up to date.
Does BIOTALYS NV (BTLS.BR) stock pay dividends?
BTLS.BR does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOTALYS NV (BTLS.BR)?
BIOTALYS NV (BTLS.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.4).
BTLS.BR Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BTLS.BR. When comparing the yearly performance of all stocks, BTLS.BR is one of the better performing stocks in the market, outperforming 87.61% of all stocks.
BTLS.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. BTLS.BR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BTLS.BR Financial Highlights
Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.4. The EPS increased by 38.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.89% | ||
| ROE | -47.77% | ||
| Debt/Equity | 0.13 |
BTLS.BR Forecast & Estimates
9 analysts have analysed BTLS.BR and the average price target is 7.58 EUR. This implies a price increase of 82.7% is expected in the next year compared to the current price of 4.15.
For the next year, analysts expect an EPS growth of -3.51% and a revenue growth -52% for BTLS.BR